115 related articles for article (PubMed ID: 12075855)
1. Protection of dopaminergic neurons in primary culture by lisuride.
Gille G; Rausch WD; Hung ST; Moldzio R; Ngyuen A; Janetzky B; Engfer A; Reichmann H
J Neural Transm (Vienna); 2002 Feb; 109(2):157-69. PubMed ID: 12075855
[TBL] [Abstract][Full Text] [Related]
2. Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture.
Moldzio R; Radad K; Duvigneau JC; Kranner B; Krewenka C; Piskernik C; Rausch WD
J Neural Transm (Vienna); 2006 Sep; 113(9):1095-105. PubMed ID: 16463121
[TBL] [Abstract][Full Text] [Related]
3. Pergolide protects dopaminergic neurons in primary culture under stress conditions.
Gille G; Rausch WD; Hung ST; Moldzio R; Janetzky B; Hundemer HP; Kolter T; Reichmann H
J Neural Transm (Vienna); 2002 May; 109(5-6):633-43. PubMed ID: 12111455
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Takashima H; Tsujihata M; Kishikawa M; Freed WJ
Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl-L-methionyl-L-Dopa-methyl ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity.
Minelli A; Conte C; Prudenzi E; Cacciatore I; Cornacchia C; Taha E; Pinnen F
Free Radic Biol Med; 2010 Jul; 49(1):31-9. PubMed ID: 20307650
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
7. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
[TBL] [Abstract][Full Text] [Related]
8. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
10. K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production.
Xie J; Duan L; Qian X; Huang X; Ding J; Hu G
J Neurosci Res; 2010 Feb; 88(2):428-37. PubMed ID: 19746425
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
Storch A; Burkhardt K; Ludolph AC; Schwarz J
J Neurochem; 2000 Dec; 75(6):2259-69. PubMed ID: 11080177
[TBL] [Abstract][Full Text] [Related]
12. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
Gille G; Radad K; Reichmann H; Rausch WD
J Neural Transm (Vienna); 2006 Sep; 113(9):1107-18. PubMed ID: 16252065
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
Callier S; Le Saux M; Lhiaubet AM; Di Paolo T; Rostène W; Pelaprat D
J Neurochem; 2002 Jan; 80(2):307-16. PubMed ID: 11902121
[TBL] [Abstract][Full Text] [Related]
15. The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models.
Jeon MY; Lee WY; Kang HY; Chung EJ
Neurol Res; 2007 Apr; 29(3):289-95. PubMed ID: 17509229
[TBL] [Abstract][Full Text] [Related]
16. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
17. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress.
Mytilineou C; Walker RH; JnoBaptiste R; Olanow CW
J Pharmacol Exp Ther; 2003 Feb; 304(2):792-800. PubMed ID: 12538835
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration.
Hartikka J; Staufenbiel M; Lübbert H
J Neurosci Res; 1992 Jun; 32(2):190-201. PubMed ID: 1357186
[TBL] [Abstract][Full Text] [Related]
19. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.
Nakao N; Nakai K; Itakura T
Brain Res; 1997 Nov; 777(1-2):202-9. PubMed ID: 9449429
[TBL] [Abstract][Full Text] [Related]
20. Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine.
Shinpo K; Kikuchi S; Sasaki H; Moriwaka F; Tashiro K
J Neurosci Res; 2000 Nov; 62(3):374-82. PubMed ID: 11054806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
